Global Topical Drug Delivery Market By Product Type (Solid Topical Formulations, Semi-Solid Topical Formulations, Liquid, Transdermal), By Application (Skin Drug, Ophthalmic Drug, Rectal Drug, Vaginal Drug, Nasal Drug), By End User (Hospitals and Private Clinics, Home Care Settings, Other), By Distribution Channel (Direct Tenders, Retail), By Region, Industry Analysis, Share, Growth, Trends, and Forecast, 2021-2028

Covid-19 Impact on Global Topical Drug Delivery Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC214049

No. of Pages : 315

The global topical drug delivery market is expected to grow from USD 95.5 billion in 2020 to USD 158 billion by 2028 at a CAGR of 6.5 % over the forecast period 2021-2028.

Market Overview:

Topical drug delivery is among the foremost effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important within the pharmaceutical industry.

The global topical drug delivery market's growth is mainly driven by the increasing cases of skin and soft tissue infections, the rising instances of eye diseases, and burns. However, other drug delivery modes like oral and injectable routes are predicted to restrain the expansion of this market during the forecast period.

Market Dynamics:

Drivers:

Growing cases of skin and tissue infections

Benefits of fridge dried products

Restraints:

Availability of other alternative drugs

Adverse effects of the product

Key Market Players:

Johnson & Johnson, Nestlé SA, Novartis AG, GlaxoSmithKline, Bausch Health Companies, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Crescita Therapeutics, Mylan, Encore Dermatology, LEO Pharma, Almirall, Aclaris Therapeutics are some of the prominent players in the global topical drug delivery market.

The market is segmented based on the below-mentioned segments:

On the Basis of Product Type: Revenue

o Solid Topical Formulations

o Semi-Solid Topical Formulations

o Liquid

o Transdermal

On the Basis of Application: Revenue

o Skin Drug

o Ophthalmic Drug

o Rectal Drug

o Vaginal Drug

o Nasal Drug

On the Basis of End-User: Revenue

o Hospitals and Private Clinics

o Home Care Settings

o Other

On the Basis of Distribution Channel: Revenue

o Direct Tenders

o Retail

On The Basis of Region: Revenue

North America

- U.S.A
- Canada
- Mexico

Europe

- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

Asia Pacific

- China
- Japan
- India
- SEA
- Australia
- Rest Of APAC

South America

- Brazil
- Argentina
- Rest of South America

Middle East & Africa

- South Africa
- Saudi Arabia
- UAE
- Rest of MEA

Report Description

Year Consideration
- Base year – 2020
- Historic Year-2017-2019
- Forecast year- 2021 to 2028

The global topical drug delivery market will be based on revenue and volume. The study covers the market share for segments, countries, regions, and players.

The regions evaluated for the global topical drug delivery market are Europe, North America, Asia Pacific, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country-level.

The report provides an in-depth pricing analysis, value chain analysis, industry road map, and micro and macro factors.

The research report further provides the attractiveness of topical drug delivery and regions based on their growth rate (CAGR), market size, and attractiveness by analyzing present and future prospects to analyze market growth and development in the future.

Also, the study focuses on market-related driving forces, restraints, potential opportunities for the market, significant developments, and advancement that serve as a key potential for investors.

The study offers an extensive evaluation of Porter's five forces analysis, SWOT analysis, and PESTEL analysis to provide data and information related to the business.

Porter's five forces model is analyzed to understand the overall competitive scenario that prevails in the market. The SWOT analysis also identifies the positive as well as the negative characteristics of market development which influences the company’s growth and development to sustain and survive in the long run. The PESTEL analysis identifies the macro (external) forces affecting the organization.

The report includes a thorough analysis of the company profiles of major companies operating in the global topical drug delivery market and a comparative evaluation based on their business overviews, product offering, geographic presence, market share, business strategy, recent developments, product development & innovations, joint ventures, partnerships, mergers & acquisitions, expansions, SWOT analysis, and key financial information. It helps in evaluating the overall competition present in the market scenario.

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Full Name

Company Name

Designation/Position

Contact

Region/Country

Message

Kindly share your specific requirement (if any), so we can get back to you with a solution

TABLE OF CONTENTS
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. SCOPE OF THE STUDY
1.3. GEOGRAPHIC SCOPE
1.4. MARKET DEFINITION
1.5. CURRENCY CONSIDERATION
1.6. YEAR CONSIDERATION
2. RESEARCH METHODOLOGY AND ASSUMPTIONS
2.1. SECONDARY RESEARCH
2.2. PRIMARY RESEARCH
2.3. MARKET BREAKUP AND DATA TRIANGULATION
2.4. MARKET SIZE ESTIMATION
2.4.1. BOTTOM UP APPROACH
2.4.2. TOP DOWN APPROACH
2.5. ASSUMPTION
3. EXECUTIVE SUMMARY
3.1. KEY MARKET INSIGHTS
3.2. SEGMENTATION OUTLOOK
3.3. COMPANY OUTLOOK
4. PREMIUM INSIGHTS
4.1. IMPACT OF COVID-19 ON MARKET
4.2. INDUSTRY ROAD MAP
4.3. INDUSTRY TREND
4.4. INDUSTRY SWOT ANALYSIS
4.5. MARKET ATTRACTIVENESS ANALYSIS
4.5.1. MARKET ATTRACTIVENESS BY SEGMENTS
4.5.1.1. TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY APPLICATION
4.5.1.2. TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY PRODUCT TYPE
4.5.1.3. TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY END-USER
4.5.1.4. TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY DISTRIBUTION CHANNEL
4.5.2. MARKET ATTRACTIVENESS BY REGION
4.5.2.1. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY COUNTRY
4.5.2.2. EUROPE TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY COUNTRY
4.5.2.3. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY COUNTRY
4.5.2.4. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY COUNTRY
4.5.2.5. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET ATTENTIVENESS BY COUNTRY
4.6. PORTER’S FIVE FORCES ANALYSIS
4.6.1. THREAT OF NEW ENTRANTS
4.6.2. THREAT OF SUBSTITUTES
4.6.3. BARGAINING POWER OF SUPPLIERS
4.6.4. BARGAINING POWER OF BUYERS
4.6.5. INTENSITY OF COMPETITIVE RIVALRY
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH & DEVELOPMENT COMPANIES
4.7.2. RAW MATERIAL/ COMPONENT SUPPLIERS
4.7.3. PRODUCT MANUFACTURERS
4.7.4. DISTRIBUTORS AND RETAILERS
4.7.5. END-USER INDUSTRIES
4.7.6. POST-SALES SERVICE PROVIDERS
4.8. FACTORS AFFECTING THE MARKET
4.8.1. MACRO FACTORS AFFECTING THE MARKET
4.8.2. MICRO FACTORS AFFECTING THE MARKET
4.8.3. PESTEL ANALYSIS
4.9. YEAR ON YEAR GROWTH RATE OF TOPICAL DRUG DELIVERY
4.10. LIST OF SUPPLIERS
4.11. LIST OF BUYERS
4.12. COUNTRY LEVEL ANALYSIS
4.13. RULES AND REGULATION
5. MARKET DYNAMICS
5.1. MARKET DRIVERS
5.1.1. GROWING CASES OF SKIN AND TISSUE INFECTIONS
5.1.2. BENEFITS OF FRIDGE DRIED PRODUCTS
5.2. MARKET RESTRAINTS
5.2.1. AVAILABILITY OF OTHER ALTERNATIVE DRUGS
5.2.2. ADVERSE EFFECTS OF THE PRODUCT
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
6. GLOBAL TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY PRODUCT TYPE - 2017-2028
6.1. KEY FINDINGS
6.2. SOLID TOPICAL FORMULATIONS
6.3. SEMI-SOLID TOPICAL FORMULATIONS
6.4. LIQUID
6.5. TRANSDERMAL
7. GLOBAL TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY APPLICATION - 2017-2028
7.1. KEY FINDINGS
7.2. SKIN DRUG
7.3. OPHTHALMIC DRUG
7.4. RECTAL DRUG
7.5. VAGINAL DRUG
7.6. NASAL DRUG
8. GLOBAL TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY END-USER - 2017-2028
8.1. KEY FINDINGS
8.2. HOSPITALS AND PRIVATE CLINICS
8.3. HOME CARE SETTINGS
8.4. OTHER
9. GLOBAL TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY DISTRIBUTION CHANNEL- 2017-2028
9.1. KEY FINDINGS
9.2. DIRECT TENDERS
9.3. RETAIL
10. GLOBAL TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY REGIONAL - 2017-2028
10.1. KEY FINDINGS
10.2. NORTH AMERICA
10.3. EUROPE
10.4. ASIA PACIFIC
10.5. SOUTH AMERICA
10.6. MIDDLE EAST & AFRICA
11. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
11.1. BY COUNTRY
11.1.1. U.S.
11.1.2. CANADA
11.1.3. MEXICO
12. EUROPE TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
12.1. BY COUNTRY
12.1.1. GERMANY
12.1.2. U.K.
12.1.3. FRANCE
12.1.4. ITALY
12.1.5. SPAIN
12.1.6. SWEDEN
12.1.7. BELGIUM
12.1.8. TURKEY
12.1.9. RUSSIA
12.1.10. POLAND
12.1.11. SWITZERLAND
12.1.12. NETHERLANDS
12.1.13. REST OF EUROPE
13. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
13.1. BY COUNTRY
13.1.1.1. JAPAN
13.1.1.2. CHINA
13.1.1.3. INDIA
13.1.1.4. AUSTRALIA
13.1.1.5. SOUTH KOREA
13.1.1.6. MALAYSIA
13.1.1.7. INDONESIA
13.1.1.8. VIETNAM
13.1.1.9. NEW ZEALAND
13.1.1.10. PHILIPPINES
13.1.1.11. TAIWAN
13.1.1.12. SINGAPORE
13.1.1.13. REST OF ASIA-PACIFIC
14. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
14.1. BY COUNTRY
14.1.1.1. BRAZIL
14.1.1.2. ARGENTINA
14.1.1.3. CHILE
14.1.1.4. COLOMBIA
14.1.1.5. REST OF SOUTH AMERICA
15. MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
15.1. BY COUNTRY
15.1.1.1. SOUTH AFRICA
15.1.1.2. U.A.E.
15.1.1.3. SAUDI ARABIA
15.1.1.4. REST OF MIDDLE EAST AND AFRICA
16. COMPETITIVE LANDSCAPE
16.1. MARKET SHARE OF KEY PLAYERS IN POWER TOOL MARKET
16.1.1. GLOBAL MARKET SHARE ANALYSIS
16.1.2. NORTH AMERICA MARKET SHARE ANALYSIS
16.1.3. EUROPE MARKET SHARE ANALYSIS
16.1.4. ASIA PACIFIC MARKET SHARE ANALYSIS
16.1.5. SOUTH AMERICA MARKET SHARE ANALYSIS
16.1.6. MIDDLE EAST & AFRICA MARKET SHARE ANALYSIS
16.2. LEADERSHIP MAPPING
16.2.1. VISIONARY PLAYERS
16.2.2. INNOVATORS PLAYERS
16.2.3. DYNAMIC DIFFERENTIATORS
16.2.4. EMERGING COMPANIES
16.3. COMPETITIVE SCENARIO AND TRENDS
16.3.1. MERGERS & ACQUISITIONS
16.3.2. PRODUCT LAUNCHES AND DEVELOPMENTS
16.3.3. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
16.3.4. EXPANSIONS
17. COMPANY PROFILES
17.1.1. JOHNSON & JOHNSON
17.1.1.1. COMPANY OVERVIEW
17.1.1.2. COMPANY SNAPSHOT
17.1.1.3. FINANCIAL ANALYSIS
17.1.1.3.1. REVENUE ANALYSIS
17.1.1.3.2. SALES ANALYSIS
17.1.1.3.3. PRICE ANALYSIS
17.1.1.3.4. MARGIN ANALYSIS
17.1.1.4. GEOGRAPHICAL PRESENCE
17.1.1.4.1. NORTH AMERICA
17.1.1.4.2. EUROPE
17.1.1.4.3. ASIA PACIFIC
17.1.1.4.4. SOUTH AMERICA
17.1.1.4.5. MIDDLE EAST & AFRICA
17.1.1.5. PRODUCT PORTFOLIO
17.1.1.6. SWOT ANALYSIS
17.1.1.7. RECENT DEVELOPMENT
17.1.2. NESTLÉ SA
17.1.3. NOVARTIS AG
17.1.4. GLAXOSMITHKLINE
17.1.5. BAUSCH HEALTH COMPANIES
17.1.6. MERCK & CO
17.1.7. BAYER AG
17.1.8. HISAMITSU PHARMACEUTICAL
17.1.9. GLENMARK PHARMACEUTICALS
17.1.10. CIPLA LTD
17.1.11. CRESCITA THERAPEUTICS
17.1.12. MYLAN
17.1.13. ENCORE DERMATOLOGY
17.1.14. LEO PHARMA
17.1.15. ALMIRALL
17.1.16. ACLARIS THERAPEUTICS
18. STRATEGIC RECOMMENDATIONS
LIST OF TABLE
1. RESEARCH ASSUMPTION
2. COVID-19 IMPACT ON MARKET
3. MAJOR DEVELOPMENTS BY VARIOUS COMPANIES
4. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
5. GLOBAL SOLID TOPICAL FORMULATIONS TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
6. GLOBAL SEMI-SOLID TOPICAL FORMULATIONS TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
7. GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
8. GLOBAL TRANSDERMAL TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
10. GLOBAL SKIN DRUG TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
11. GLOBAL OPHTHALMIC DRUG TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
12. GLOBAL RECTAL DRUG TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
13. GLOBAL VAGINAL DRUG TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
14. GLOBAL NASAL DRUG TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
15. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
16. GLOBAL HOSPITALS AND PRIVATE CLINICS TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
17. GLOBAL HOME CARE SETTINGS TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
18. GLOBAL OTHER TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
19. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
20. GLOBAL DIRECT TENDERS TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
21. GLOBAL RETAIL TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
22. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY NORTH AMERICA, 2017–2028 REVENUE (USD MILLION)
23. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
24. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
25. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
26. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
27. U.S. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
28. U.S. TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
29. U.S. TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
30. U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
31. CANADA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
32. CANADA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
33. CANADA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
34. CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
35. MEXICO TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
36. MEXICO TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
37. MEXICO TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
38. MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
39. EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
40. EUROPE TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
41. EUROPE TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
42. EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
43. GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
44. GERMANY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
45. GERMANY TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
46. GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
47. FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
48. FRANCE TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
49. FRANCE TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
50. FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
51. U.K. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
52. U.K. TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
53. U.K. TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
54. U.K. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
55. ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
56. ITALY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
57. ITALY TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
58. ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
59. SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
60. SPAIN TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
61. SPAIN TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
62. SPAIN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
63. SWEDEN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
64. SWEDEN TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
65. SWEDEN TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
66. SWEDEN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
67. BELGIUM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
68. BELGIUM TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
69. BELGIUM TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
70. BELGIUM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
71. TURKEY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
72. TURKEY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
73. TURKEY TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
74. TURKEY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
75. RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
76. RUSSIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
77. RUSSIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
78. RUSSIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
79. POLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
80. POLAND TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
81. POLAND TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
82. POLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
83. SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
84. SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
85. SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
86. SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
87. NETHERLANDS TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
88. NETHERLANDS TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
89. NETHERLANDS TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
90. NETHERLANDS TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
91. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
92. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
93. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
94. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
95. JAPAN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
96. JAPAN TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
97. JAPAN TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
98. JAPAN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
99. CHINA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
100. CHINA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
101. CHINA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
102. CHINA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
103. INDIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
104. INDIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
105. INDIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
106. INDIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
107. AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
108. AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
109. AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
110. AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
111. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
112. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
113. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
114. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
115. INDONESIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
116. INDONESIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
117. INDONESIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
118. INDONESIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
119. VIETNAM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
120. VIETNAM TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
121. VIETNAM TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
122. VIETNAM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
123. NEW ZEALAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
124. NEW ZEALAND TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
125. NEW ZEALAND TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
126. NEW ZEALAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
127. PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
128. PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
129. PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
130. PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
131. TAIWAN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
132. TAIWAN TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
133. TAIWAN TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
134. TAIWAN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
135. TAIWAN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNELR, 2017–2028 REVENUE (USD MILLION)
136. SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
137. SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
138. SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
139. SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNELR, 2017–2028 REVENUE (USD MILLION)
140. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
141. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
142. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
143. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNELR, 2017–2028 REVENUE (USD MILLION)
144. BRAZIL TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
145. BRAZIL TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
146. BRAZIL TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
147. BRAZIL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
148. ARGENTINA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
149. ARGENTINA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
150. ARGENTINA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
151. ARGENTINA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
152. CHILE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
153. CHILE TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
154. CHILE TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
155. CHILE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
156. COLOMBIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
157. COLOMBIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
158. COLOMBIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
159. COLOMBIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
160. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
161. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
162. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
163. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
164. UAE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
165. UAE TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
166. UAE TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
167. UAE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
168. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
169. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
170. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
171. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
172. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
173. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
174. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
175. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)
176. REST OF MEATOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017–2028 REVENUE (USD MILLION)
177. REST OF MEATOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017–2028 REVENUE (USD MILLION)
178. REST OF MEATOPICAL DRUG DELIVERY MARKET, BY END-USER, 2017–2028 REVENUE (USD MILLION)
179. REST OF MEATOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2017–2028 REVENUE (USD MILLION)

LIST OF FIGURE
1. RESEARCH DESIGN
2. SCOPE OF THE STUDY
3. GEOGRAPHIC SCOPE
4. CURRENCY CONSIDERATION
5. YEAR CONSIDERATION
6. MARKET ESTIMATION
7. RESEARCH METHODOLOGY
8. DATA TRIANGULATION
9. COVID-19 IMPACT ON MARKET
10. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
11. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY PRODUCT TYPE
12. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY END-USER
13. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY DISTRIBUTION CHANNEL
14. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY REGION
15. GLOBAL TOPICAL DRUG DELIVERY MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
16. GLOBAL TOPICAL DRUG DELIVERY MARKET: DYNAMICS
17. PESTEL ANALYSIS
18. SWOT ANALYSIS
19. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY REGION
20. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY APPLICATION
21. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY PRODUCT TYPE
22. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY END-USER
23. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
24. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY NORTH AMERICA
25. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY EUROPE
26. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY ASIA PACIFIC
27. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY SOUTH AMERICA
28. GLOBAL TOPICAL DRUG DELIVERY MARKET ANALYSIS BY MIDDLE EAST & AFRICA
29. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)
30. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)
31. EUROPE TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)
32. ASIA PACIFIC TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)
33. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)
34. MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SHARE BY COMPANY (2020)